A PYMNTS Company

US: California AG sues Abbvie for illegal kickbacks

By  |  September 23, 2018

Pharmaceutical company Abbvie had its shares drop about 3% last week after California’s insurance commissioner Dave Jones sued the company, alleging Abbvie has been providing kickbacks in the form of nursing support and insurance assistance to prompt doctors to write prescriptions for its arthritis drug Humira.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    Subscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Mr. Jones, who filed a complaint in Alameda County Superior Court, alleges the company’s “Ambassador” program was intended to “keep patients on a dangerous drug at any cost.”

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    AbbVie claimed in a statement that it “operates in compliance with the many state and federal laws that govern interactions with healthcare providers and patients.”

    Credit Suisse analysts said that the lawsuit could have extensive repercussions in the drug industry since the kickback practices “are similar to what other biopharma companies have also used to help patients start and stay on medications that their doctor prescribes.”

    Full Content: Bloomberg & The Wall Street Journal

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.